Atai Life Sciences N.V. (ATAI)
NASDAQ: ATAI · Real-Time Price · USD
2.200
-0.050 (-2.22%)
At close: Jun 27, 2025, 4:00 PM
2.229
+0.029 (1.32%)
After-hours: Jun 27, 2025, 7:54 PM EDT
Atai Life Sciences Market Cap
Atai Life Sciences has a market cap or net worth of $441.66 million as of June 27, 2025. Its market cap has increased by 88.45% in one year.
Market Cap
441.66M
Enterprise Value
372.42M
1-Year Change
88.45%
Ranking
Category
Stock Price
$2.20
Market Cap Chart
Since the IPO on June 18, 2021, Atai Life Sciences's market cap has decreased from $2.29B to $441.66M, a decrease of -80.70%. That is a compound annual growth rate of -33.55%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Jun 26, 2025 | 451.69M | 102.39% |
| Dec 31, 2024 | 223.18M | -4.66% |
| Dec 29, 2023 | 234.07M | -46.95% |
| Dec 30, 2022 | 441.23M | -63.92% |
| Dec 31, 2021 | 1.22B | -46.56% |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Eli Lilly and Company | 713.81B |
| Johnson & Johnson | 365.75B |
| AbbVie | 329.95B |
| Novo Nordisk | 299.93B |
| UnitedHealth Group | 274.52B |
| Novartis AG | 235.02B |
| Abbott Laboratories | 232.56B |
| AstraZeneca | 216.45B |